OFD1 and glioblastoma: Compared with normal tissues, the expression of OFD1 aberrantly increased in multiple cancers, including colorectal cancer, glioblastoma, renal cancer, liver cancer, lung cancer, and prostate cancer (Supplementary Fig. 6c).